Alerts will be sent to your verified email
Verify Email
PREVEST
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Prevest Denpro Limited produces a wide range of dental materials to diagnose, treat, and prevent dental conditions, catering to various dentistry fields. Its products are distributed across Europe, Asia, South America, Middle East, and Africa.
Prevest Denpro major competitors are Medicamen Biotech, Kilitch Drugs(India), Jenburkt Pharma, Shivalik Rasayan, Albert David, Medico Remedies, Trident Lifeline.
Market Cap of Prevest Denpro is ₹535 Crs.
While the median market cap of its peers are ₹504 Crs.
Prevest Denpro seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Aug | Jun Sep Dec | Sep | |||||||||||||||
| Investor Presentation | May Nov | Feb Mar Jun Sep Dec | Mar Jun Sep Dec | Feb May Jun Aug Sep Dec | Jun Sep | |||||||||||||
| Conference Call | Mar Nov | Mar Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
